Boström P A
Department of Medicine, University of Lund, Malmö General Hospital, Sweden.
Clin Cardiol. 1988 Jan;11(1):35-8. doi: 10.1002/clc.4960110114.
In order to evaluate the therapeutic effects of metoprolol, nifedipine, and their combination, 11 patients with secondary angina pectoris and with thallium tomographic findings indicating coronary artery disease were studied before and after these three treatment regimes in a single-blind cross-over study. The therapeutic effect was measured by standardized working test and isotope angiocardiography, which enabled evaluation of left ventricular ejection fraction, stroke volume, and phase analysis of left ventricular contraction. Treatment with metoprolol and combination therapy increased work performance. Ejection fraction did not differentiate the treatment regimes, whereas stroke volume was significantly lower at work and heart rate higher at rest and at work during nifedipine treatment compared to either metoprolol or combination treatment (p less than 0.05). Cardiac output was significantly reduced during nifedipine and metoprolol treatment during work (p less than 0.05). Phase improved after all therapeutic regimes, but reached significance only during the metoprolol treatment period at rest (p less than 0.05).
为了评估美托洛尔、硝苯地平及其联合用药的治疗效果,在一项单盲交叉研究中,对11例继发性心绞痛且铊断层扫描结果显示患有冠状动脉疾病的患者在这三种治疗方案前后进行了研究。通过标准化工作测试和同位素心血管造影来测量治疗效果,这能够评估左心室射血分数、每搏输出量以及左心室收缩的相位分析。美托洛尔治疗和联合治疗提高了工作能力。射血分数无法区分治疗方案,而与美托洛尔或联合治疗相比,硝苯地平治疗期间工作时的每搏输出量显著降低,静息时和工作时的心率更高(p<0.05)。工作期间硝苯地平和美托洛尔治疗时心输出量显著降低(p<0.05)。所有治疗方案后相位均有改善,但仅在美托洛尔治疗静息期达到显著水平(p<0.05)。